Your session is about to expire
← Back to Search
Combination Therapy for HIV/AIDS
Study Summary
This trial will study whether a combination of different drugs can help control HIV in people who stop taking antiretroviral therapy (ART).
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have an active hepatitis C infection.I haven't had or expected to have cancer treatment, except for HIV-related, in the last 3 years.My tests show high resistance to specific treatments.I am 67 or younger, starting treatment early, or under 65 if starting late.I have a history of immune conditions, but not just Raynaud's or issues treated with creams only.I am taking medication that is not a non-nucleoside reverse transcriptase inhibitor.I have had cancer linked to HIV, like Kaposi's sarcoma or lymphoma.I've been on stable HIV treatment without NNRTIs for over a year without breaks longer than 2 weeks.
- Group 1: Combination intervention arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this clinical experiment currently seeking participants?
"According to the information presented on clinicaltrials.gov, this medical trial is now closed for enrollment. It was initially suggested on August 1st 2020 and had its most recent update released on March 21st 2022. Currently, there are 515 other trials actively recruiting participants from around the world."
Does the eligibility for this trial extend to individuals below 25 years of age?
"Eligible candidates for this medical trial must be between 18 and 67 years old. For those under 18, there are 113 other clinical trials available; additionally, 379 studies exist specifically tailored to senior citizens."
Who is the ideal candidate for this research project?
"This clinical trial is searching for 11 individuals with Acquired Immunodeficiency Syndrome (AIDS) who are aged between 18 and 67. To be eligible, patients must have been receiving antiretroviral therapy without any interruptions of greater than 14 consecutive days within the last year on a stable regimen that does not include a non-nucleoside reverse transcriptase inhibitor (NNRTI). Additionally, those being treated during early infection can only apply if they are ≤67 years at time of enrollment whereas those starting treatment in chronic infection must be <65 years old."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger